IQVIA Holdings Inc IQV
There have not been any declared dividends recently.
|Summary||Previous dividend||Next dividend|
Enter the number of IQVIA Holdings Inc shares you hold and we'll calculate your dividend payments:
Sign up for IQVIA Holdings Inc and we'll email you the dividend information when they declare.
Add IQVIA Holdings Inc to receive free notifications when they declare their dividends.
Your account is set up to receive IQVIA Holdings Inc notifications.
|Status||Type||Decl. date||Ex-div date||Pay date||Decl. Currency||Forecast amount||Decl. amount||Accuracy|
|There are no IQVIA Holdings Inc dividends.|
|2022||Sign Up Required|
IQVIA Holdings Inc Optimized Dividend Chart
About IQVIA Holdings Inc
IQVIA Holdings Inc., formerly Quintiles IMS Holdings, Inc., incorporated on October 3, 2016, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. It serves pharmaceutical, biotechnology, medical device and healthcare companies. The Company has its operations in the Americas, Europe and Africa, and the Asia-Pacific.
The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services. The Company provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment and promotional activity across multiple channels including retail, hospital and mail order. These solutions are an integral part of processes in life science companies around the world and are also used by the investment and financial sectors that deal with life science companies. It also provides a measurement of sales or prescribing activity at the regional, zip code and individual prescriber level (depending on regulation in the relevant country). As of December 31, 2016, its reference database tracked over 14 million healthcare professionals in over 70 countries, providing a view of healthcare practitioners.
The Company enables clients to use patient-level data to understand treatments, outcomes, and costs to inform and advance healthcare decision making. With patient privacy and security safeguards, it offers data assets that integrate medical claims, prescriptions, electronic medical records, biomarkers and government statistics as needed for research requirements. It provides a range of cloud-based applications and associated implementation services. Software-as-a-service (SaaS) solutions support a range of commercial and regulatory processes, including multi-channel marketing, customer relationship management (CRM), performance management, incentive compensation, territory alignment, roster management, call planning, compliance reporting and master data management. These solutions are used by healthcare companies to manage, optimize and execute their commercial strategies in an orchestrated manner while addressing their regulatory obligations. As of December 31, 2016, using algorithms, the Company combined its country-level data, healthcare expertise and therapeutic knowledge in over 100 countries to create its Global Market Insight family of offerings, such as MIDAS, Analytics Link and Disease Insights. It provides a set of consulting services, including analytics and commercial processes outsourcing services.
Research & Development Solutions
The Research & Development Solutions segment provides biopharmaceutical development services. It offers project management and clinical monitoring, clinical trial support services, Q2 solutions, and strategic planning and design. Its clinical solutions and services' service offerings include protocol design, feasibility and operational planning, site start up and patient recruitment. It offers a range of functional services and consultation to support clinical trials through specialized expertise that help clients collect, analyze and report the quality data and evidence they need to gain regulatory approval. It provides its clients globally scaled end-to-end clinical trial laboratory and research services. It offers clinical trial, genomic, and bioanalytical laboratory service offerings within the joint venture, which is referred to as Q2 Solutions. Through its strategic planning and design services, it offers consultation services.
Integrated Engagement Services
The Integrated Engagement Services segment offerings include healthcare provider engagement services, patient engagement services, and scientific strategy and medical affairs services. Its patient engagement services combine insight from clinical trials and social listening, behavioral design, personal and eHealth multichannel interactions across multiple sites (such as the physician's office, hospital, pharmacy, home). The Company partners with biopharmaceutical companies and other life sciences providers (such as medical device companies) to develop and deploy stakeholder engagement solutions, including contract sales and market access professionals.
The Company competes with Accenture, Cognizant Technology Solutions, Covance Inc., Deloitte, Evidera, GfK, LexisNexis Risk Solutions, IBM, Infosys, inVentiv Health, Inc., Kantar Health, McKinsey, Nielsen N.V., OptumInsight, Parexel International Corporation, Inc., Press Ganey, RTI Health Solutions, Symphony Health Solutions, Synovate Healthcare, The Advisory Board, Trizetto, Veeva, Verisk Analytics, Inc., ZS Associates, Pharmaceutical Product Development, Inc., PAREXEL International Corporation, ICON plc, INC Research Holdings, PRA International, Laboratory Corporation of America Holdings, United Drug plc, EPS Corporation and CMIC HOLDINGS Co., Ltd.
- Health Care Equipment & Services
- United States
- Share Price
- $203.39 (yesterday's closing price)
- Shares in Issue
- 196 million
- Market Cap
- Market Indices
- S&P 500